Overexpression and phosphorylation of EGFR, which are prevalent mechanisms in epithelial malignancies, are linked to poor prognosis, metastasis, and chemotherapy resistance, making it a suitable target for cancer therapy. This evidence concerns the gene EGFR and cancer.